Cited by 466Cancer survivorship and careHealth Education and ValidationChildhood Cancer Survivors' Quality of Life

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale

McQuellon, RP, Russell, GB, Cella, DF, Craven, BL, Brady, M, Bonomi, A, Hurd, DD·1997·Bone Marrow Transplantation

Open this paper in CoChat — free account

Abstract

We developed a 12-item bone marrow transplant subscale (BMTS) for the general Functional Assessment of Cancer Therapy (FACT) measure. The subscale combined with the FACT, (FACT-BMT) is a 47-item, valid and reliable measure of five dimensions of quality of life in bone marrow transplant patients. The three-step validation process involved the generation and selection of BMT-specific items and the testing of the overall measure. Items were selected from a list produced by seven oncology experts and 15 patients and were designed to assess content not represented in the general FACT items. A total of 182 patients completed the FACT-BMT at baseline, prior to BMT. An analysis measuring sensitivity to change was performed with 74 patients after transplantation and 60 patients over the three time-points of baseline, hospital discharge and 100 days. The FACT-BMT and all subscales were correlated, sensitivity to change was measured, and the internal consistency for each scale was calculated. Coefficients of reliability and validity ranged from 0.86 to 0.89 for the entire FACT-BMT and 0.54 to 0.63 for the BMTS. The BMTS was able to discriminate patients on the basis of performance status rating and also demonstrated sensitivity to change over time. The FACT-BMT has good psychometric properties for use in assessing quality of life in bone marrow transplant patients. The addition of the bone marrow transplant subscale to the general FACT measure makes it an excellent choice for use in BMT clinical trials.

Integrity signals

Registry

Crossref · 10.1038/sj.bmt.1700672

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The MOS social support survey
Sherbourne, C. D., & Stewart, A. L. (1991) · Social Science & Medicine · doi:10.1016/0277-9536(91)90150-b · Cited by 6,643

Show all 1 references

Sorted by citations

The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation.
(2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-79 · Cited by 1,506
Self-citation
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report
Pavletic, S. Z., Martin, P. J., Lee, S. J., Mitchell, S. A., Jacobsohn, D. A., Cowen, E. W., Turner, M. L. C., Akpek, G., Gilman, A. L., McDonald, G. B., et al. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.01.008 · Cited by 566
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
Lee, S. J., Wolff, D., Kitko, C. L., Koreth, J., Inamoto, Y., Jagasia, M., Pidala, J., Olivieri, A., Martin, P. J., Przepiorka, D., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.02.025 · Cited by 447
Nonmalignant late effects after allogeneic stem cell transplantation
Socié, G. (2003) · Blood · doi:10.1182/blood-2002-07-2231 · Cited by 416
Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation
El-Jawahri, A. R., LeBlanc, T. W., Vandusen, H. B., Traeger, L. N., Greer, J. A., Pirl, W. F., Jackson, V. A., Telles, J., Rhodes, A., Spitzer, T. R., et al. (2016) · JAMA · doi:10.1001/jama.2016.16786 · Cited by 399
Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium
Pidala, J., Kurland, B. F., Chai, X., Majhail, N. S., Weisdorf, D. J., Pavletic, S. Z., Cutler, C. S., Jacobsohn, D. A., Palmer, J. M., Arai, S., et al. (2011) · Blood · doi:10.1182/blood-2010-11-319509 · Cited by 393
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial
Walker, I., Panzarella, T., Couban, S., Couture, F., Devins, G. M., Elemary, M., Gallagher, G., Kerr, H. M., Kuruvilla, J. G., Lee, S. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00462-3 · Cited by 365
Quality of life after allogeneic hematopoietic cell transplantation
Pidala, J., Anasetti, C., & Jim, H. (2009) · Blood · doi:10.1182/blood-2008-10-182592 · Cited by 316
Classification systems for chronic graft-versus-host disease
Lee, S. J. (2016) · Blood · doi:10.1182/blood-2016-07-686642 · Cited by 313
Acute graft-versus-host disease
Malard, F., Holler, E., Sandmaier, B. M., Huang, H., & Mohty, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00438-1 · Cited by 301
Reliability and validity of the functional assessment of cancer therapy-ovarian
Basen-Engquist, K., Bodurka-Bevers, D., Fitzgerald, M. A., Webster, K., Cella, D., Hu, S., & Gershenson, D. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1809 · Cited by 280
Self-citation
Measuring quality of life in chronic illness: The functional assessment of chronic illness therapy measurement system
Cella, D. F., & Nowinski, C. J. (2002) · Archives of Physical Medicine and Rehabilitation · doi:10.1053/apmr.2002.36959 · Cited by 279
Self-citation
Development and validation of a scale to measure symptoms of chronic graft-versus-host disease
Lee, S. J., Cook, E. F., Soiffer, R. J., & Antin, J. H. (2002) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2002.v8.pm12234170 · Cited by 246
Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial
El-Jawahri, A. R., Traeger, L. N., Greer, J. A., Vandusen, H. B., Fishman, S. R., LeBlanc, T. W., Pirl, W. F., Jackson, V. A., Telles, J., Rhodes, A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.2800 · Cited by 234
Quality of life associated with acute and chronic graft-versus-host disease
Lee, S. J., Kim, H. T., Ho, V. T., Cutler, C. S., Alyea, E. P., Soiffer, R. J., & Antin, J. H. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705434 · Cited by 233
Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation
El‐Jawahri, A. R., Traeger, L. N., Kuzmuk, K., Eusebio, J. R., Vandusen, H. B., Shin, J. A., Keenan, T., Gallagher, E. R., Greer, J. A., Pirl, W. F., et al. (2015) · Cancer · doi:10.1002/cncr.29149 · Cited by 218
Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year
McQuellon, R. P., Russell, G., Rambo, T. D., Craven, B., Radford, J., Perry, J. J., Cruz, J. M., & Hurd, D. D. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701115 · Cited by 205
Self-citation
Comparison of Two Quality-of-Life Instruments for Cancer Patients: The Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30
Kemmler, G., Holzner, B., Kopp, M., Dünser, M., Margreiter, R., Greil, R., & Sperner‐Unterweger, B. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2932 · Cited by 196
Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia
El-Jawahri, A. R., LeBlanc, T. W., Kavanaugh, A. R., Webb, J. A., Jackson, V. A., Campbell, T. C., O’Connor, N. R., Luger, S. M., Gafford, E. F., Gustin, J., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.6343 · Cited by 193
Reliability and Validity of the Functional Assessment of Chronic Illness Therapy-Palliative Care (FACIT-Pal) Scale
Lyons, K. D., Bakitas, M. A., Hegel, M. T., Hanscom, B. S., Hull, J. G., & Ahles, T. A. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.12.015 · Cited by 190
Longitudinal Study of Adaptation to the Stress of Bone Marrow Transplantation
Fife, B. L., Huster, G. A., Cornetta, K. G., Kennedy, V. N., Akard, L. P., & Broun, E. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1539 · Cited by 181
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years
Wong, R. S. M., Giralt, S. A., Martin, T. G., Couriel, D. R., Anagnostopoulos, A., Hosing, C. M., Andersson, B. S., Cano, P., Shahjahan, M., Ippoliti, C. M., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0855 · Cited by 171
A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation
Hjermstad, M. J., Knobel, H., Brinch, L., Fayers, P. M., Loge, J. H., Holte, H., & Kaasa, S. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704561 · Cited by 166
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome
Nakamura, R., Saber, W., Martens, M. J., Ramirez, A., Scott, B. L., Oran, B., Leifer, E., Tamari, R., Mishra, A., Maziarz, R. T., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03380 · Cited by 151
Long-Term Medical Outcomes and Quality-of-Life Assessment of Patients With Chronic Myeloid Leukemia Followed at Least 10 Years After Allogeneic Bone Marrow Transplantation
Kiss, T. L., Abdolell, M., Jamal, N., Minden, M. D., Lipton, J. H., & Messner, H. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.077 · Cited by 147
Recovery After Stem-Cell Transplantation for Hematologic Diseases
Lee, S. J., Fairclough, D. L., Parsons, S. K., Soiffer, R. J., Fisher, D. C., Schlossman, R. L., Antin, J. H., & Weeks, J. C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.242 · Cited by 145
Prospective study of religious coping among patients undergoing autologous stem cell transplantation
Sherman, A. C., Plante, T. G., Simonton, S., Latif, U., & Anaissie, E. J. (2009) · Journal of Behavioral Medicine · doi:10.1007/s10865-008-9179-y · Cited by 141
Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization
Victorson, D., Barocas, J., Song, J., & Cella, D. (2008) · Quality of Life Research · doi:10.1007/s11136-008-9398-2 · Cited by 141
Self-citation
Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation
El‐Jawahri, A. R., Vandusen, H. B., Traeger, L. N., Fishbein, J. N., Keenan, T., Gallagher, E. R., Greer, J. A., Pirl, W. F., Jackson, V. A., Spitzer, T. R., et al. (2016) · Cancer · doi:10.1002/cncr.29818 · Cited by 137
Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation
Lee, S. J., Logan, B. R., Westervelt, P., Cutler, C. S., Woolfrey, A. E., Khan, S. P., Waller, E. K., Maziarz, R. T., Wu, J., Shaw, B. E., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.2520 · Cited by 131
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report
Martin, P. J., Lee, S. J., Przepiorka, D., Horowitz, M. M., Koreth, J., Vogelsang, G. B., Walker, I., Carpenter, P. A., Griffith, L. M., Akpek, G., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.05.004 · Cited by 126
Symptom burden in patients undergoing autologous stem-cell transplantation
Anderson, K. O., Giralt, S. A., Mendoza, T. R., Brown, J. O., Neumann, J. L., Mobley, G. M., Wang, X. S., & Cleeland, C. S. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705664 · Cited by 126
Health‐related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention
Pidala, J., Anasetti, C., & Jim, H. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07992.x · Cited by 127
Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease
Kurosawa, S., Oshima, K., Yamaguchi, T., Yanagisawa, A., Fukuda, T., Kanamori, H., Mori, T., Takahashi, S., Kondo, T., Kohno, A., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.06.011 · Cited by 123
Quality of life: a new perspective for cancer patients
Fallowfield, L. J. (2002) · Nature reviews. Cancer · doi:10.1038/nrc930 · Cited by 116
Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia
Nasa, G. L., Caocci, G., Efficace, F., Dessì, C., Vacca, A., Piras, E., Sanna, M., Marcias, M., Littera, R., Carcassi, C., et al. (2013) · Blood · doi:10.1182/blood-2013-05-502658 · Cited by 114
Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation
Heinonen, H. S., Volin, L., Uutela, A. K., Zevon, M. A., Barrick, C., & Ruutu, T. (2001) · Annals of Hematology · doi:10.1007/s002770000249 · Cited by 112
Quality of life concerns and depression among hematopoietic stem cell transplant survivors
Mosher, C. E., DuHamel, K. N., Rini, C. K., Corner, G. W., Lam, J., & Redd, W. H. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0958-y · Cited by 111
Changes in Quality-of-Life and Psychosocial Adjustment among Multiple Myeloma Patients Treated with High-Dose Melphalan and Autologous Stem Cell Transplantation
Sherman, A. C., Simonton, S., Latif, U., Plante, T. G., & Anaissie, E. J. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.09.023 · Cited by 110
Quality of Life in Colorectal Cancer Patients with Colectomy and the Validation of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C), Version 4
Yoo, H. J., Kim, J. C., Eremenco, S. L., & Han, O. S. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.12.009 · Cited by 104
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial
Walker, I., Panzarella, T., Couban, S., Couture, F., Devins, G. M., Elemary, M., Gallagher, G., Kerr, H. M., Kuruvilla, J. G., Lee, S. J., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30220-0 · Cited by 103
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.
Shpall, E. J., Wheeler, C., Turner, S. A., Yanovich, S., Brown, R. A., Pecora, A. L., Shea, T. C., Mangan, K. F., WILLIAMS, S. F., LeMaistre, C. F., et al. (1999) · PubMed · doi:10.1182/blood.v93.8.2491 · Cited by 101
Gender-associated differences in the quality of life after allogeneic BMT
Heinonen, H. S., Volin, L., Uutela, A. K., Zevon, M. A., Barrick, C., & Ruutu, T. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703158 · Cited by 98
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Pidala, J., Kim, J., Jim, H., Kharfan‐Dabaja, M. A., Nishihori, T., Fernandez, H. F., Tomblyn, M. R., Perez, L. E., Perkins, J. B., Xu, M., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.067140 · Cited by 98
Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
Bevans, M. F., Marden, S. F., Leidy, N. K., Soeken, K. L., Cusack, G., Rivera, P., Mayberry, H., Bishop, M. R., Childs, R. W., & Barrett, A. J. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705406 · Cited by 97
Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials
Pavletic, S. Z., Lee, S. J., Socié, G., & Vogelsang, G. B. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705490 · Cited by 95
Quality of life and social integration after allogeneic hematopoietic SCT
Bieri, S., Roosnek, E. E., Helg, C., Verholen, F., Robert, D. V., Chapuis, B., Passweg, J. R., Miralbell, R., & Chalandon, Y. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.253 · Cited by 94
Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study
Pidala, J., Vogelsang, G. B., Martin, P., Chai, X., Storer, B. E., Pavletic, S. Z., Weisdorf, D. J., Jagasia, M., Cutler, C. S., Palmer, J. M., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.055186 · Cited by 92
National Institutes of Health Chronic Graft-versus-Host Disease Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis
Baird, K., Steinberg, S. M., Grkovic, L. D., Pulanić, D., Cowen, E. W., Mitchell, S. A., Williams, K. M., Datiles, M. B., Bishop, R. J., Bassim, C. W., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.01.013 · Cited by 92
Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes In Chronic Graft-Versus-Host Disease
Palmer, J. M., Williams, K. M., Inamoto, Y., Chai, X., Martin, P. J., Tomas, L. H. S., Cutler, C. S., Weisdorf, D. J., Kurland, B. F., Carpenter, P. A., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.11.025 · Cited by 91
Organ‐specific management and supportive care in chronic graft‐versus‐host disease
Dignan, F. L., Scarisbrick, J. J., Cornish, J., Clark, A., Amrolia, P. J., Jackson, G. H., Mahendra, P., Taylor, P. C., Shah, P. L., Lightman, S., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09131.x · Cited by 88
Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients
Fiuza‐Luces, C., Simpson, R. J., Ramírez, M. R., Lucía, A., & Berger, N. A. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.195 · Cited by 91
Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life
Sun, Y.-C., Chai, X., Inamoto, Y., Pidala, J., Martin, P. J., Flowers, M. E. D., Shen, T. T., Lee, S. J., & Jagasia, M. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.05.020 · Cited by 87
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial
Pidala, J., Hamadani, M., Dawson, P. M., Martens, M. J., Alousi, A. M., Jagasia, M., Efebera, Y. A., Chhabra, S., Pusic, I., Holtan, S. G., et al. (2019) · Blood · doi:10.1182/blood.2019003125 · Cited by 86
Prognostic understanding, quality of life and mood in patients undergoing hematopoietic stem cell transplantation
El-Jawahri, A. R., Traeger, L. N., Kuzmuk, K., Eusebio, J. R., Vandusen, H. B., Keenan, T. E., Shin, J. A., Gallagher, E. R., Greer, J. A., Pirl, W. F., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.113 · Cited by 86
Economic survivorship stress is associated with poor health‐related quality of life among distressed survivors of hematopoietic stem cell transplantation
Hamilton, J. G., Wu, L. M., Austin, J. E., Valdimarsdottir, H. B., Basmajian, K., Vu, A., Rowley, S. D., Isola, L. M., Redd, W. H., & Rini, C. K. (2012) · Psycho-Oncology · doi:10.1002/pon.3091 · Cited by 81
Health-related quality of life in survivors of BMT for paediatric malignancy: a systematic review of the literature
Clarke, S., Eiser, C., & Skinner, R. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.156 · Cited by 79
Late complications after hematopoietic stem cell transplantation
Tichelli, A., Rovó, A., Passweg, J. R., Schwarze, C. P., Lint, M. T. V., Arat, M., & Socié, G. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.48 · Cited by 78
Fertility and sexual function in long‐term survivors of haematological malignancy: using patient‐reported outcome measures to assess a neglected area of need in the late effects clinic
Greaves, P., Sarker, S., Chowdhury, K., Johnson, R., Matthews, J., Matthews, R., Smith, M., Korszun, A., Gribben, J. G., & Lister, T. A. (2013) · British Journal of Haematology · doi:10.1111/bjh.12651 · Cited by 71
Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease
El-Jawahri, A. R., Pidala, J., Khera, N., Wood, W. A., Arora, M., Carpenter, P. A., Palmer, J. M., Flowers, M. E. D., Jagasia, M., Chen, Y., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.07.020 · Cited by 68
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study
Boberg, E., von Bahr, L., Afram, G., Lindström, C., Ljungman, P. T., Heldring, N., Petzelbauer, P., Legert, K. G., Kadri, N., & Blanc, K. L. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0099 · Cited by 67
Caregiver Quality of Life After Autologous Bone Marrow Transplantation
Boyle, D., Blodgett, L., Gnesdiloff, S., White, J., Bamford, A. M., Sheridan, M., & Beveridge, R. A. (2000) · Cancer Nursing · doi:10.1097/00002820-200006000-00006 · Cited by 66
Quality of Life, Quality of Care, and Patient Satisfaction: Perceptions of Patients Undergoing Outpatient Autologous Stem Cell Transplantation
Schulmeister, L., Quiett, K., & Mayer, K. (2005) · Oncology nursing forum · doi:10.1188/05.onf.57-67 · Cited by 65
Preliminary psychometric evaluation of the Child Health Ratings Inventory (CHRIs) and Disease-Specific Impairment Inventory-Hematopoietic Stem Cell Transplantation (DSII-HSCT) in parents and children
Parsons, S. K., Shih, M., Mayer, D. K., Barlow, S. E., Supran, S. E., Levy, S. L., Greenfield, S., & Kaplan, S. H. (2005) · Quality of Life Research · doi:10.1007/s11136-005-1004-2 · Cited by 65
Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial
Tay, J., Allan, D., Chatelain, E., Coyle, D., Elemary, M., Fulford, A., Petrcich, W., Ramsay, T., Walker, I., Xenocostas, A., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01836 · Cited by 66
Development and validation of a Patient-Reported Oral Mucositis Symptom (PROMS) scale.
Kushner, J., Lawrence, H. P., Shoval, I., Kiss, T. L., Devins, G. M., Lee, L., & Tenenbaum, H. C. (2008) · PubMed · Cited by 65
Health-Related Quality of Life after Autologous Stem Cell Transplantation for Multiple Myeloma
Chakraborty, R., Hamilton, B. K., Hashmi, S. K., Kumar, S. K., & Majhail, N. S. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.03.027 · Cited by 65
Reliability and validity of the compliance belief scales among patients with heart failure
Bennett, S. J., Perkins, S. M., Lane, K. A., Forthofer, M. M., Brater, D. C., & Murray, M. D. (2001) · Heart & Lung · doi:10.1067/mhl.2001.114193 · Cited by 63
Quality of life measurement Will we ever be satisfied?
Bonomi, A. E., Patrick, D. L., Bushnell, D. M., & Martin, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00121-3 · Cited by 63
Self-citation
Validation of the Human Activity Profile Questionnaire in Patients after Allogeneic Hematopoietic Stem Cell Transplantation
Herzberg, P. Y., Heußner, P., Mumm, F., Horak, M., Hilgendorf, I., von Harsdorf, S., Hemmati, P., Rieger, K., Greinix, H., Freund, M., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.05.018 · Cited by 62
A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer
Lee, W. R., McQuellon, R. P., Harris‐Henderson, K., Case, L. D., & McCullough, D. L. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00355-7 · Cited by 61
Self-citation
Personal Financial Effects of Multiple Myeloma and Its Treatment
Goodwin, J. A., Coleman, E. A., Sullivan, E., Easley, R., McNatt, P., Chowdhury, N., & Stewart, C. B. (2012) · Cancer Nursing · doi:10.1097/ncc.0b013e3182693522 · Cited by 60
Impact of Age on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease
El-Jawahri, A. R., Pidala, J., Inamoto, Y., Chai, X., Khera, N., Wood, W. A., Cutler, C. S., Arora, M., Carpenter, P. A., Palmer, J. M., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.05.001 · Cited by 60
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease
Martin, P. J., Storer, B. E., Inamoto, Y., Flowers, M. E. D., Carpenter, P. A., Pidala, J., Palmer, J. M., Arora, M., Jagasia, M., Arai, S., et al. (2017) · Blood · doi:10.1182/blood-2017-03-775767 · Cited by 60
Centralized patient‐reported outcome data collection in transplantation is feasible and clinically meaningful
Shaw, B. E., Brazauskas, R., Millard, H. R., Fonstad, R. K., Flynn, K. E., Abernethy, A. P., Vogel, J., Petroske, C., Mattila, D., Drexler, R. J., et al. (2017) · Cancer · doi:10.1002/cncr.30936 · Cited by 58
Harnessing benefits of helping others: A randomized controlled trial testing expressive helping to address survivorship problems after hematopoietic stem cell transplant.
Rini, C. K., Austin, J., Wu, L. M., Winkel, G. H., Valdimarsdottir, H. B., Stanton, A. L., Isola, L. M., Rowley, S. D., & Redd, W. H. (2013) · Health Psychology · doi:10.1037/hea0000024 · Cited by 57
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD
Jagasia, M., Scheid, C., Socié, G., Ayuk, F. A., Tischer, J., Donato, M. L., Bátai, Á., Chen, H., Chen, S., Chin, T., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000145 · Cited by 57
EARLY QUALITY OF LIFE ASSESSMENT IN MEN TREATED WITH PERMANENT SOURCE INTERSTITIAL BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER
Lee, W. R., McQuellon, R. P., Case, L. D., deGuzman, A. F., & McCullough, D. L. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68570-9 · Cited by 57
Self-citation
Malnutrition in patients with chronic GVHD
Bassim, C. W., Fassil, H., Dobbin, M., Steinberg, S., Baird, K., Cole, K. M., Joe, G. O., Comis, L. E., Mitchell, S. A., Grkovic, L. D., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.145 · Cited by 56
Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G
King, M. T., Stockler, M. R., Cella, D. F., Osoba, D., Eton, D. T., Thompson, J., & Eisenstein, A. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.05.001 · Cited by 58
Self-citation
Positive Psychological Constructs and Health Outcomes in Hematopoietic Stem Cell Transplantation Patients: A Systematic Review
Amonoo, H. L., Barclay, M. E., El-Jawahri, A. R., Traeger, L. N., Lee, S. J., & Huffman, J. C. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.09.030 · Cited by 57
Psychosocial aspects of hematopoietic stem cell transplantation
Janicsák, H., Ungvari, G. S., & Gazdag, G. (2021) · World Journal of Transplantation · doi:10.5500/wjt.v11.i7.263 · Cited by 55
Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivors
Kenzik, K. M., Huang, I., Rizzo, J. D., Shenkman, E. A., & Wingard, J. R. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2420-z · Cited by 55
Self‐efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well‐being after hematopoietic stem cell transplant
Wu, L. M., Austin, J., Hamilton, J. G., Valdimarsdottir, H. B., Isola, L. M., Rowley, S. D., Warbet, R., Winkel, G. H., Redd, W. H., & Rini, C. K. (2011) · Psycho-Oncology · doi:10.1002/pon.2012 · Cited by 54
Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem-Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16
Crump, M., Glück, S., Tu, D., Stewart, D., Levine, M. N., Kirkbride, P., Dancey, J. E., O'Reilly, S., Shore, T. B., Couban, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8851 · Cited by 54
The impact of allogeneic-hematopoietic stem cell transplantation on patients' and close relatives' quality of life and relationships
Poloméni, A., Lapusan, S., Bompoint, C., Rubio, M., & Mohty, M. (2015) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2015.10.011 · Cited by 53
A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia
McErlean, G., Gilroy, N. M., Bradford, J. A., Brice, L., Kabir, M., Greenwood, M. J., Larsen, S. R., Moore, J. J., Hertzberg, M., Kwan, J., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13872 · Cited by 53
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients
Huang, L., Sheng, Y., Andreadis, C. B., Logan, A. C., Mannis, G. N., Smith, C. C., Gaensler, K. M. L., Martin, T. G., Damon, L. E., Steinman, M. A., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.08.022 · Cited by 53
Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment
Kopp, M., Schweigkofler, H., Holzner, B., Nachbaur, D., Niederwieser, D. W., Fleischhacker, W. W., & Sperner‐Unterweger, B. (1998) · Annals of Hematology · doi:10.1007/s002770050407 · Cited by 53
Longitudinal health-related quality of life outcomes and related factors after pediatric SCT
Barrera, M. E., Atenafu, E. G., & Hancock, K. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.24 · Cited by 52
Clinical Benefit of Response in Chronic Graft-versus-Host Disease
Inamoto, Y., Martin, P. J., Chai, X., Jagasia, M., Palmer, J. M., Pidala, J., Cutler, C. S., Pavletic, S. Z., Arora, M., Jacobsohn, D. A., et al. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.05.016 · Cited by 52
Distress and quality of life in patient and caregiver dyads facing stem cell transplant: identifying overlap and unique contributions
Sannes, T. S., Simoneau, T. L., Mikulich‐Gilbertson, S. K., Natvig, C. L., Brewer, B. W., Kilbourn, K. M., & Laudenslager, M. L. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4496-3 · Cited by 52
Rationale and Design of the Chronic GVHD Cohort Study: Improving Outcomes Assessment in Chronic GVHD
(2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.05.007 · Cited by 52
Finding benefit from cancer.
Tallman, B. A., ALTMAIER, E. M., & Garcia, C. (2007) · Journal of Counseling Psychology · doi:10.1037/0022-0167.54.4.481 · Cited by 52
Qualitative findings on the experience of end-of-life care for hematological malignancies
McGrath, P. D. (2002) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910201900208 · Cited by 51
Quality of life related to oral mucositis of patients undergoing haematopoietic stem cell transplantation and receiving specialised oral care with low-level laser therapy: a prospective observational study
Bezinelli, L. M., Eduardo, F. D. P., Neves, V. D., Côrrea, L., Lopes, R. M. G., Michel‐Crosato, E., Hamerschlak, N., & Biazevic, M. G. H. (2015) · European Journal of Cancer Care · doi:10.1111/ecc.12344 · Cited by 51
Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium
Pidala, J., Kurland, B. F., Chai, X., Vogelsang, G. B., Weisdorf, D. J., Pavletic, S. Z., Cutler, C. S., Majhail, N. S., & Lee, S. J. (2011) · Haematologica · doi:10.3324/haematol.2011.046367 · Cited by 51
Course of Cognitive Decline in Hematopoietic Stem Cell Transplantation: A Within-subjects Design
Friedman, M. A., Fernandez, M. I., Wefel, J. S., Myszka, K. A., Champlin, R. E., & Meyers, C. A. (2009) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acp060 · Cited by 50
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network
Laport, G. G., Wu, J., Logan, B. R., Bachanová, V., Hosing, C. M., Fenske, T. S., Longo, W., Devine, S. M., Nademanee, A. P., Gersten, I. D., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.04.014 · Cited by 50
A randomized control trial of stress management for caregivers of stem cell transplant patients: Effect on patient quality of life and caregiver distress
Laudenslager, M. L., Simoneau, T. L., Mikulich‐Gilbertson, S. K., Natvig, C. L., Brewer, B. W., Sannes, T. S., Kilbourn, K. M., Gutman, J., & McSweeney, P. A. (2019) · Psycho-Oncology · doi:10.1002/pon.5126 · Cited by 49

Authors: McQuellon, R., Russell, G., Cella, D., Craven, B., Brady, M., Bonomi, A., & Hurd, D.
Affiliations: Atrium Health Wake Forest Baptist (US)
Rush University Medical Center (US)
ORCID: Bonomi, A
Venue: Bone Marrow Transplantation
Publisher: Springer Science and Business Media LLC
Published: 1997-02-01
Volume: 19
Issue: 4
Pages: 357-368
ISSN: 0268-3369 (ISSN-L)
1476-5365
DOI: 10.1038/sj.bmt.1700672
OpenAlex: W1975020079
Cited by: 466
References: 1
Citations by year: 2026: 24 · 2025: 25 · 2024: 39 · 2023: 31 · 2022: 21 · 2021: 28 · 2020: 29 · 2019: 24 · 2018: 26 · 2017: 16 · 2016: 17 · 2015: 27 · 2014: 12 · 2013: 16 · 2012: 18
FWCI: 1.82
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Bone Marrow Transplantation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (2s07rr005404-31)
National Center for Research Resources (RR-05404)
Topics: Health Sciences › Medicine › Oncology › Cancer survivorship and care
Health Sciences › Nursing › Research and Theory › Health Education and Validation
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
Keywords: quality of life, FACT-BMT, Functional Assessment of Cancer Therapy, psychometric validation, sensitivity to change, performance status, patient-reported outcomes, clinical trial outcome measures
MeSH terms: Adolescent, Adult, Female, Humans, Male, Middle Aged, Neoplasms, Psychometrics, Quality of Life, Surveys and Questionnaires, Bone Marrow Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks